OVID

NASDAQStock

Ovid Therapeutics Inc.

$1.99-0.03 (-1.24%)

52-Week Range

$0.26

$2.14

Key Stats

Market Cap

141.4M

P/E Ratio

—

Dividend Yield

—

Beta

0.16

Volume

846.2K

Avg Volume

2.1M

Performance

+34.00%

+28.85%

+57.03%

YTD

+14.20%

+363.24%

-3.83%

-51.21%

Price Chart

ETF Exposure

OVID is held by 9 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
QQQS	Invesco NASDAQ Future Gen 200 ETF	0.56%	37,116	$77K	$13.4M	0.20%
SURI	Simplify Propel Opportunities ETF	0.35%	130,813	$263K	$76.9M	2.82%
VXF	Vanguard Extended Market ETF	0.00%	622,296	$971K	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	98	$208	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	3,528	$7K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	17	$36	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	2,008,716	$3.1M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	10,565	$22K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	911	$2K	$1.29B	0.17%

About OVID ETF Exposure

Ovid Therapeutics Inc. (OVID) is held by 9 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 141.4M, OVID is a widely held institutional stock. The stock currently trades at $1.99. Investors can gain exposure to OVID through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold OVID, sorted by portfolio weight.